Literature DB >> 29236649

Deadly Sphenoid Fungus-Isolated Sphenoid Invasive Fungal Rhinosinusitis: A Case Report.

Jason E Gilde1, Christopher C Xiao2, Victoria A Epstein3, Jonathan Liang4.   

Abstract

INTRODUCTION: Acute invasive fungal rhinosinusitis (AIFRS) is a potentially fatal infection, usually affecting immunocompromised patients. Isolated sphenoid sinus involvement is rare and has been reported in only a few cases. We discuss the clinical characteristics, histopathologic features, and differential diagnosis of AIFRS of the sphenoid sinus. CASE
PRESENTATION: A 57-year-old man with a history of refractory non-Hodgkin lymphoma and neutropenia presented with a 1-week duration of left-sided headache and ipsilateral cheek paresthesia. Nasal endoscopy showed mucoid drainage from the sphenoethmoidal recess. Magnetic resonance imaging demonstrated left sphenoid mucosal thickening and enhancement along the adjacent skull base. The patient underwent endoscopic sinus surgery with extended sphenoidotomy and débridement. The lateral wall and recess of the left sphenoid sinus demonstrated pale mucosa and fungal debris. Pathologic analysis demonstrated necrotic tissue and fungal hyphae with angioinvasion. Microbiology studies isolated Aspergillus fumigatus. The right maxillary sinus contained a synchronous fungal ball, which was removed during surgery; there was no evidence of tissue necrosis or invasive fungus in the maxillary sinus. He was treated with long-term voriconazole therapy, and 6-month follow-up showed disease resolution. DISCUSSION: AIFRS should be considered in the differential diagnosis of immunocompromised patients with nonspecific sinonasal symptoms. Usually, AIFRS is diffuse with multiple sinus involvement; however, isolated sphenoid AIFRS can occur. This is one of the few cases of AIFRS demonstrating isolated sphenoid involvement and is thought to be the first case showing a synchronous noninvasive fungal ball of another sinus cavity. Prompt recognition and surgical treatment may be curative and lifesaving.

Entities:  

Mesh:

Year:  2017        PMID: 29236649      PMCID: PMC5718708          DOI: 10.7812/TPP/17-032

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  20 in total

1.  Prognosis of acute invasive fungal rhinosinusitis related to underlying disease.

Authors:  Fabiana C P Valera; Tassiana do Lago; Edwin Tamashiro; Camila Carrara Yassuda; Flávia Silveira; Wilma T Anselmo-Lima
Journal:  Int J Infect Dis       Date:  2011-10-02       Impact factor: 3.623

2.  Acute invasive fungal rhinosinusitis: our experience with 19 patients.

Authors:  Ahmet Emre Süslü; Oğuz Oğretmenoğlu; Nilda Süslü; Omer TaşkIn Yücel; Tevfik Metin Onerci
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-10       Impact factor: 2.503

Review 3.  Clinical features and outcome of sphenoid sinus aspergillosis: A retrospective series of 15 cases.

Authors:  A Thery; F Espitalier; E Cassagnau; N Durand; O Malard
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2012-03-22       Impact factor: 2.080

4.  Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature.

Authors:  P C Iwen; M E Rupp; S H Hinrichs
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

5.  Impact of surgical treatment on paranasal fungal infections in bone marrow transplant patients.

Authors:  C A Kennedy; G L Adams; J P Neglia; G S Giebink
Journal:  Otolaryngol Head Neck Surg       Date:  1997-06       Impact factor: 3.497

6.  Invasive fungal rhinosinusitis: a 15-year experience with 29 patients.

Authors:  Marcus M Monroe; Max McLean; Nathan Sautter; Mark K Wax; Peter E Andersen; Timothy L Smith; Neil D Gross
Journal:  Laryngoscope       Date:  2013-02-16       Impact factor: 3.325

7.  Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.

Authors:  Raoul Herbrecht; Thomas F Patterson; Monica A Slavin; Oscar Marchetti; Johan Maertens; Elizabeth M Johnson; Haran T Schlamm; J Peter Donnelly; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2014-11-19       Impact factor: 9.079

8.  Orbital and cranial nerve presentations and sequelae are hallmarks of invasive fungal sinusitis caused by Mucor in contrast to Aspergillus.

Authors:  Avani P Ingley; Shatul L Parikh; John M DelGaudio
Journal:  Am J Rhinol       Date:  2008 Mar-Apr

9.  Update on the optimal use of voriconazole for invasive fungal infections.

Authors:  Asma Lat; George R Thompson
Journal:  Infect Drug Resist       Date:  2011-02-03       Impact factor: 4.003

10.  Voriconazole in the management of nosocomial invasive fungal infections.

Authors:  Javier Pemán; Miguel Salavert; Emilia Cantón; Isidro Jarque; Eva Romá; Rafael Zaragoza; Angel Viudes; Miguel Gobernado
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

View more
  1 in total

1.  A Case of Invasive Sphenoid Sinus Aspergillosis Presenting as Oculomotor Nerve Palsy in a Healthy Patient.

Authors:  Takashi Fujimoto; Yoichi Morofuji; Takeshi Hiu; Koichi Yoshida; Koichi Izumikawa; Takeshi Watanabe; Takayuki Matsuo
Journal:  NMC Case Rep J       Date:  2021-06-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.